
CEO and part owner, ZYDUS PHARMACEUTICALS USA INC
Member of the Healthcare Council
Joseph D. Renner, MBA, is CEO of Zydus Pharmaceuticals (USA) Inc., the US affiliate of Zydus Cadila, an Indian generic pharmaceutical manufacturer. Prior to this, Mr. Renner was the EVP/COO of Geneva Pharmaceuticals, a generics manufacturer and division of Novartis. In addition, Mr. Renner spent 17 years at Bristol Meyers Squibb in various capacities including Director of Biochem Sales and Head of Marketing and Business Development for Apothecon, the generics division. (This is me - Update Profile)
G+ is a community for professionals, academics and entrepreneurs to connect through online discussions and in-person meetings. You will continue to see G+ Insights (formerly GLG News) here as well as on the G+ website, where you can share and discuss the G+ Insights you read.
Joe Renner has not published any GLG News Analyses.
| Study Group Name | No. Members |
|---|---|
| Generic Drug Economic Experts | 887 |
| Formulary Design Experts | 258 |
| Zocor Pricing Experts (US) | 34 |
| Economic Experts: Pharmaceutical Contract Manufacturing and Analytical Services (US) | 22 |
Joe Renner has not participated in any GLG Live Meetings.